Menu

Infographic: Repurposing Strategies

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

Dec 31, 2016
Anna Azvolinsky

 

Types of patents in the U.S.

PATENT VERSUS EXCLUSIVITY

Patents: Granted by the US Patent and Trademark Office (or an analogous agency in another country). Patents generally last for 20 years.

Exclusivity: Granted by the FDA upon drug approval. Exclusive marketing rights, which
range from six months to seven years, give a manufacturer sole promotion rights of a drug for a certain indication as an incentive for drug innovation and prevention of generic drug competition.

Off-label drug use: When a drug is used in a different disease, administered in a different
way or at a different dose than what has been specified in the drug’s label (based on clinical trial data reviewed by the FDA for approval). Any drug on the market can be prescribed on an off-label basis at doctors’ discretion.

Read the full story.

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics
Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows. Kit developed as part of licensing and supply agreement with Cygnus Technologies
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT launches ultra-high performance CRISPR Cas12a enzyme
IDT’s new CRISPR Cas12a (Cpf1) Ultra enzyme can target new sites within the genome and with greater efficiency
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen Launches New NanoPhotometer N120: The High Throughput Champion!
Implen GmbH is excited to announce the release of the NanoPhotometer® N120, an absorbance based UV/VIS Multi Channel Spectrophotometer.
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
StemExpress Announces Release of New Frozen Leukopak® to Advance Research
To continue to provide new products and services to further advance medical research around the world, today, StemExpress announced the release of their Frozen Leukopak®.